20 July 2023 - EMA has expanded the scope of the OPEN initiative from COVID-19 vaccines and treatments to a ...
17 November 2022 - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make ...
24 August 2022 - The TGA has updated its list of applications for new medicines or new uses for existing ...
15 June 2022 - The US FDA needs to take a more proactive approach in combatting misinformation and communicating decisions to ...
18 February 2022 - Historically, the US FDA has considered much of the oversight of clinical trials, interactions with companies, and ...
19 January 2022 - Data should be fully and immediately available for public scrutiny ...
23 August 2021 - Through its Public Release of Clinical Information initiative, Health Canada has provided public access to a vast ...
7 May 2021 - The International Coalition of Medicines Regulatory Authorities and the World Health Organisation are urging pharmaceutical companies to ...
30 April 2021 - The US FDA on Friday revoked a policy issued in the final days of the Trump ...
4 February 2021 - EMA is piloting a new ‘OPEN’ initiative to increase international collaboration on the evaluation of COVID-19 vaccines ...
30 October 2020 - Today the EMA has implemented two further extra transparency measures for COVID-19 medicines, by publishing both ...
9 October 2020 - The Australian Government has given approval to proceed with two measures to enhance transparency for prescription ...
7 October 2020 - The FDA has laid out its safety standards for developers of COVID-19 vaccines after the White House ...
5 October 2020 - The EMA has re-affirmed today that it will uphold its long-standing commitment to independence and transparency ...
29 September 2020 - The FDA has issued a number of contentious decisions during the COVID-19 pandemic related to investigational ...